Genetic markers predicting sulphonylurea treatment outcomes in type 2 diabetes patients: current evidence and challenges for clinical implementation.
about
Identification of genetic variants in pharmacogenetic genes associated with type 2 diabetes in a Mexican-Mestizo populationBrief Report: The Role of Rare Protein-Coding Variants in Anti-Tumor Necrosis Factor Treatment Response in Rheumatoid Arthritis.Precision medicine in diabetes prevention, classification and management.
P2860
Genetic markers predicting sulphonylurea treatment outcomes in type 2 diabetes patients: current evidence and challenges for clinical implementation.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Genetic markers predicting sul ...... s for clinical implementation.
@en
type
label
Genetic markers predicting sul ...... s for clinical implementation.
@en
prefLabel
Genetic markers predicting sul ...... s for clinical implementation.
@en
P2093
P2860
P356
P1476
Genetic markers predicting sul ...... s for clinical implementation.
@en
P2093
N K Loganadan
S R Vethakkan
P2860
P2888
P304
P356
10.1038/TPJ.2015.95
P577
2016-01-26T00:00:00Z
P5875
P6179
1024364761